SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Add-Life Pharma Ltd (524665)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524665 NSE: Pharmaceuticals & Drugs | Small Cap | Add-Life Pharma Share Price

BSE Share Price
Not Listed

Add-Life Pharma Ltd (524665)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524665 NSE: Pharmaceuticals & Drugs | Small Cap | Add-Life Pharma Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹7 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹0
TTM Sales
₹1.1 Cr.
Book Value per Share
₹9.7
P/E Ratio
0.00
Industry PE
46.5
Price to Book (P/B)
0.05
Price to Sales (P/S)
6.11
EV/EBITDA
128.49
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
-0.03%
Return on Capital Employed (ROCE)
-0.03%
Return on Assets (ROA)
-0.03%
Operating Profit Margin
3.1%
Net Profit Margin
-2.84%
Gross Profit Margin
3.1%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
₹-4 Cr.
Equity
₹149.2 Cr.
Face Value
₹10
All Time Low / High
₹0.46 / 37.50

Add-Life Pharma stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05TTM
ROCE % -11%-10.4%-37.2%-14.2%-0.3%-0%-

Growth Parameters

Sales 10.100.501.61
Sales YoY Gr.--92.3%-50%1,050%-100%NA-
Adj EPS -1.2-1-2-0.6-0-00
YoY Gr.-NANANANANA-
BVPS (₹) 6.96.13.73.19.79.79.7
Adj Net
Profit
-0.6-0.5-1.1-0.3-0.2-0.10
Cash Flow from Ops. 0.20.1-0.20.10-0-
Debt/CF from Ops. 5.616.9-3.510.50-18.2-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA9.4%244.1%NA
Adj EPS NANANANA
BVPSNA7.2%38%0%
Share Price - - - -

Key Financial Parameters

Mar'99Mar'00Mar'01Mar'02Mar'04Mar'05TTM
Return on
Equity %
-14.7-13.4-35.2-16.1-0.3-00
Op. Profit
Mgn %
-33.4-377.3-1742.4-35.503.17.3
Net Profit
Mgn %
-59.2-665.9-2477.9-74.20-2.80
Debt to
Equity
0.30.30.40.300-
Working Cap
Days
04,0895,87338001010
Cash Conv.
Cycle
03,6685,061-2370370

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'04Mar'05
Sales1.040.080.040.4601.63
Operating Expenses + 1.390.381.190.730.131.58
Manufacturing Costs0.350.110.200.0100
Material Costs0.550.030.340.4801.43
Employee Cost 0.070.050.05000.02
Other Costs 0.420.190.600.250.130.13
Operating Profit -0.36-0.30-1.14-0.28-0.130.05
Operating Profit Margin (%) -34.5%-381.0%-2,701.9%-61.0%-3.1%
Other Income + 00.020.050.0500
Exceptional Items 000000
Interest 0.120.080.080.0700
Depreciation 0.150.170.160.120.100.10
Profit Before Tax -0.62-0.53-1.33-0.42-0.22-0.05
Tax 000000
Profit After Tax -0.62-0.53-1.33-0.42-0.22-0.05
PAT Margin (%) -60.0%-668.0%-3,149.3%-92.1%--2.8%
Adjusted EPS (₹)-1.2-1.0-2.5-0.8-0.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%

Valuation of Add-Life Pharma - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'04Mar'05

Equity and Liabilities

Shareholders Fund + 4.183.652.311.90145.80145.75
Share Capital 5.265.265.265.26149.76149.76
Reserves -1.08-1.61-2.94-3.36-3.96-4.01
Debt +0.980.820.790.530.480.47
Long Term Debt0.980.820.790.530.480.47
Short Term Debt000000
Minority Interest000000
Trade Payables000.310.310.250.25
Others Liabilities 0.130.210.090.020.020.02
Total Liabilities 5.284.683.512.76146.56146.49

Fixed Assets

Net Fixed Assets +3.423.242.382.041.541.44
Gross Block3.853.832.982.702.222.22
Accumulated Depreciation0.430.600.590.660.680.78
CWIP 0.040.040000
Investments 0.010.010.010.01144.50144.51
Inventories0.730.700.48000.02
Trade Receivables0.15000.340.340.50
Cash Equivalents 0.290.140.170.050.030
Others Assets 0.640.550.460.320.150.02
Total Assets 5.284.683.512.76146.56146.49

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'05
Cash Flow From Operating Activity + 0.170.05-0.220.05-0.03
PBT -0.62-0.53-1.33-0.42-0.05
Adjustment 0.370.320.690.350.19
Changes in Working Capital 0.430.250.420.12-0.17
Tax Paid 00000
Cash Flow From Investing Activity + 0.170.030.370.160
Capex -0.030.010.280.110
Net Investments 00000
Others 0.200.020.090.050
Cash Flow From Financing Activity + -0.31-0.23-0.11-0.340
Net Proceeds from Shares 00000
Net Proceeds from Borrowing -0.08-0.15-0.01-0.160
Interest Paid -0.12-0.08-0.08-0.070
Dividend Paid 00000
Others -0.110-0.02-0.110
Net Cash Flow 0.04-0.150.04-0.13-0.03

Financial Ratio

PARTICULARSMar'99Mar'00Mar'01Mar'02Mar'04Mar'05
Ratios
ROE (%)-17.17-15.48-51.92-23.53-0.3-0.03
ROCE (%)-10.99-10.41-37.22-14.17-0.3-0.03
Asset Turnover Ratio0.20.020.010.1500.01
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days52.20348.1018.30137.10094
Inventory Days257.903,320.305,090.60003.80
Payable Days00169.60240064.50

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Add-Life Pharma Ltd FAQs

The current trading price of Add-Life Pharma on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Add-Life Pharma stood at ₹6.86 Cr

The latest P/E ratio of Add-Life Pharma as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Add-Life Pharma as of 31-Dec-1969 is 0.05.

The 52-week high of Add-Life Pharma is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Add-Life Pharma is ₹1.12 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Add-Life Pharma Ltd

Add-Life Pharma Limited (ADDLP) which was initially incorporated as a private limited company on January 11, 1991, was promoted by Shri Ishwarbhai Patel, Shri Rameshbhai Patel and their associates. Subsequently, it was reorganized with the induction of Dr Bharat I Patel in September, 1992 and the Company was converted into AddLife Pharma Limited on May 17, 1993.

The company is involved in the production of pharmaceuticals. The firm manufactures Ethambutol HCL, an anti-Tuberculosis drug, cotton dressings, and drug intermediaries at its manufacturing unit situated in Mehsana district of Gujarat. The drug Ethambutol HCL, manufactured by the firm, enjoys a decent standing and is suitably acknowledged in the pharma market. The drug has been removed from BSE in relation of non acquiescence with registering concurrence clauses.

The registered office is located at 412-2/C, Payal Complex, Opposite Fortune Towers, Sayajigunj, Vadodara-390005, Gujarat.

Product Portfolio

  • Ethambutol
  • L2 Amino Butanol
  • Sodium Naphthionate
  • Chemical Intermediate
  • Other Raw Materials
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×